BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity

We examined BRCA1/2 mutations and single nucleotide polymorphisms (SNPs) for identification of BRCA1 haplotypes, in early-onset breast cancer patients and their relatives, sporadic breast cancer patients, and unrelated normal healthy females, of Indian ethnicity. Peripheral blood DNA was amplified b...

Full description

Saved in:
Bibliographic Details
Published inMedical oncology (Northwood, London, England) Vol. 29; no. 5; pp. 3272 - 3281
Main Authors Juwle, Abida, Saranath, Dhananjaya
Format Journal Article
LanguageEnglish
Published Boston Springer US 01.12.2012
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We examined BRCA1/2 mutations and single nucleotide polymorphisms (SNPs) for identification of BRCA1 haplotypes, in early-onset breast cancer patients and their relatives, sporadic breast cancer patients, and unrelated normal healthy females, of Indian ethnicity. Peripheral blood DNA was amplified by polymerase chain reaction, at BRCA1/2 coding exons and subject to nucleotide sequencing using ABI 3100 Genetic Analyzer. We observed BRCA1/BRCA2 mutations in 52 % early-onset breast cancer patients and in 57 % relatives. Deleterious mutations detected in early-onset patients and relatives were 187delAG, 632insT, 1052delT, Q759X, Q780X, R1203X, 5154delC, IVS14 + 1G > A, IVS17 + 1G > T, and 632insT in BRCA1 gene; and 4075delGT, 5076delAA, 6079delAGTT, and W3127X in BRCA2 gene. A high degree of penetrance of BRCA1/2 gene mutations was observed in the relatives. BRCA1/2 SNPs were identified in the Indian population, and association of BRCA1 haplotypes with breast cancer was investigated. A significantly increased frequency of the SNPs 203G/A, 3624A/G and 7470A/G SNPs in BRCA2 gene was observed in normal controls indicative of a protective effect of the SNPs. BRCA1 haplotype 2 was most frequently observed in our population. Our study indicates a high incidence of BRCA1/BRCA2 gene mutations in the Indian patients. The BRCA1/2 mutations and SNPs are detailed on our website http://relibrca.rellife.com .
AbstractList We examined BRCA1/2 mutations and single nucleotide polymorphisms (SNPs) for identification of BRCA1 haplotypes, in early-onset breast cancer patients and their relatives, sporadic breast cancer patients, and unrelated normal healthy females, of Indian ethnicity. Peripheral blood DNA was amplified by polymerase chain reaction, at BRCA1/2 coding exons and subject to nucleotide sequencing using ABI 3100 Genetic Analyzer. We observed BRCA1/BRCA2 mutations in 52 % early-onset breast cancer patients and in 57 % relatives. Deleterious mutations detected in early-onset patients and relatives were 187delAG, 632insT, 1052delT, Q759X, Q780X, R1203X, 5154delC, IVS14 + 1G > A, IVS17 + 1G > T, and 632insT in BRCA1 gene; and 4075delGT, 5076delAA, 6079delAGTT, and W3127X in BRCA2 gene. A high degree of penetrance of BRCA1/2 gene mutations was observed in the relatives. BRCA1/2 SNPs were identified in the Indian population, and association of BRCA1 haplotypes with breast cancer was investigated. A significantly increased frequency of the SNPs 203G/A, 3624A/G and 7470A/G SNPs in BRCA2 gene was observed in normal controls indicative of a protective effect of the SNPs. BRCA1 haplotype 2 was most frequently observed in our population. Our study indicates a high incidence of BRCA1/BRCA2 gene mutations in the Indian patients. The BRCA1/2 mutations and SNPs are detailed on our website http://relibrca.rellife.com.
We examined BRCA1/2 mutations and single nucleotide polymorphisms (SNPs) for identification of BRCA1 haplotypes, in early-onset breast cancer patients and their relatives, sporadic breast cancer patients, and unrelated normal healthy females, of Indian ethnicity. Peripheral blood DNA was amplified by polymerase chain reaction, at BRCA1/2 coding exons and subject to nucleotide sequencing using ABI 3100 Genetic Analyzer. We observed BRCA1/BRCA2 mutations in 52 % early-onset breast cancer patients and in 57 % relatives. Deleterious mutations detected in early-onset patients and relatives were 187delAG, 632insT, 1052delT, Q759X, Q780X, R1203X, 5154delC, IVS14 + 1G > A, IVS17 + 1G > T, and 632insT in BRCA1 gene; and 4075delGT, 5076delAA, 6079delAGTT, and W3127X in BRCA2 gene. A high degree of penetrance of BRCA1/2 gene mutations was observed in the relatives. BRCA1/2 SNPs were identified in the Indian population, and association of BRCA1 haplotypes with breast cancer was investigated. A significantly increased frequency of the SNPs 203G/A, 3624A/G and 7470A/G SNPs in BRCA2 gene was observed in normal controls indicative of a protective effect of the SNPs. BRCA1 haplotype 2 was most frequently observed in our population. Our study indicates a high incidence of BRCA1/BRCA2 gene mutations in the Indian patients. The BRCA1/2 mutations and SNPs are detailed on our website http://relibrca.rellife.com .We examined BRCA1/2 mutations and single nucleotide polymorphisms (SNPs) for identification of BRCA1 haplotypes, in early-onset breast cancer patients and their relatives, sporadic breast cancer patients, and unrelated normal healthy females, of Indian ethnicity. Peripheral blood DNA was amplified by polymerase chain reaction, at BRCA1/2 coding exons and subject to nucleotide sequencing using ABI 3100 Genetic Analyzer. We observed BRCA1/BRCA2 mutations in 52 % early-onset breast cancer patients and in 57 % relatives. Deleterious mutations detected in early-onset patients and relatives were 187delAG, 632insT, 1052delT, Q759X, Q780X, R1203X, 5154delC, IVS14 + 1G > A, IVS17 + 1G > T, and 632insT in BRCA1 gene; and 4075delGT, 5076delAA, 6079delAGTT, and W3127X in BRCA2 gene. A high degree of penetrance of BRCA1/2 gene mutations was observed in the relatives. BRCA1/2 SNPs were identified in the Indian population, and association of BRCA1 haplotypes with breast cancer was investigated. A significantly increased frequency of the SNPs 203G/A, 3624A/G and 7470A/G SNPs in BRCA2 gene was observed in normal controls indicative of a protective effect of the SNPs. BRCA1 haplotype 2 was most frequently observed in our population. Our study indicates a high incidence of BRCA1/BRCA2 gene mutations in the Indian patients. The BRCA1/2 mutations and SNPs are detailed on our website http://relibrca.rellife.com .
We examined BRCA1/2 mutations and single nucleotide polymorphisms (SNPs) for identification of BRCA1 haplotypes, in early-onset breast cancer patients and their relatives, sporadic breast cancer patients, and unrelated normal healthy females, of Indian ethnicity. Peripheral blood DNA was amplified by polymerase chain reaction, at BRCA1/2 coding exons and subject to nucleotide sequencing using ABI 3100 Genetic Analyzer. We observed BRCA1/BRCA2 mutations in 52 % early-onset breast cancer patients and in 57 % relatives. Deleterious mutations detected in early-onset patients and relatives were 187delAG, 632insT, 1052delT, Q759X, Q780X, R1203X, 5154delC, IVS14 + 1G > A, IVS17 + 1G > T, and 632insT in BRCA1 gene; and 4075delGT, 5076delAA, 6079delAGTT, and W3127X in BRCA2 gene. A high degree of penetrance of BRCA1/2 gene mutations was observed in the relatives. BRCA1/2 SNPs were identified in the Indian population, and association of BRCA1 haplotypes with breast cancer was investigated. A significantly increased frequency of the SNPs 203G/A, 3624A/G and 7470A/G SNPs in BRCA2 gene was observed in normal controls indicative of a protective effect of the SNPs. BRCA1 haplotype 2 was most frequently observed in our population. Our study indicates a high incidence of BRCA1/BRCA2 gene mutations in the Indian patients. The BRCA1/2 mutations and SNPs are detailed on our website http://relibrca.rellife.com .
Author Saranath, Dhananjaya
Juwle, Abida
Author_xml – sequence: 1
  givenname: Abida
  surname: Juwle
  fullname: Juwle, Abida
  organization: Molecular Medicine, Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd
– sequence: 2
  givenname: Dhananjaya
  surname: Saranath
  fullname: Saranath, Dhananjaya
  email: saranathd@aol.com
  organization: Molecular Medicine, Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22752604$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtLHTEYhkNR6qX9AW4k4MbN9OQymSRLPdhWkCq2he5CJvlGR-ZkxiSzOP_eHI9CEVoXuSye5yN53wO0E8YACB1R8oUSIheJMsJZRWhZTNeV_oD2qRC6opz-2Sl3LmRFREP20EFKD4QwKpj-iPYYk4I1pN5H4fx2eUYXm53hOwiAV3O2uR9DWvz8cZOwDR4_M_jeTsOY1xMk3AcMNg7rqmCQcRvBpoydDQ4inooOISc8dvgy-N4WON-H3vV5_QntdnZI8PnlPES_v178Wn6vrq6_XS7PripXE5Er6uumVaRz2rMaGq49sdZ2nPqW-q5theS14oqLtu5aabnmsibOE-G006oDfohOt3OnOD7OkLJZ9cnBMNgA45wMlUIxrpVq3kdZCbkpvCroyRv0YZxjKB8pAzlTslCkUMcv1NyuwJsp9isb1-Y19ALILeDimFKEzpRonjPP0faDocRs6jXbek2p12zqNbqY9I35Ovx_Dts6qbDhDuJfj_6n9AQwQbRS
CODEN MONCEZ
CitedBy_id crossref_primary_10_1007_s12282_022_01374_w
crossref_primary_10_1016_j_prp_2022_153760
crossref_primary_10_1007_s11033_022_07129_2
crossref_primary_10_3390_cancers13040881
crossref_primary_10_1140_epjp_s13360_024_05961_y
crossref_primary_10_1186_s12920_020_00850_6
crossref_primary_10_1039_C5RA14442F
crossref_primary_10_1177_03000605211070757
crossref_primary_10_4103_CRST_CRST_101_19
crossref_primary_10_1007_s12291_025_01313_4
crossref_primary_10_1016_j_humgen_2022_201085
crossref_primary_10_1016_j_genrep_2019_100380
crossref_primary_10_3390_cimb46050281
crossref_primary_10_1186_s12885_018_4537_9
crossref_primary_10_4048_jbc_2013_16_1_50
crossref_primary_10_1007_s13277_016_5322_5
crossref_primary_10_1186_s12885_015_1516_2
crossref_primary_10_18632_oncotarget_16242
Cites_doi 10.1007/s10549-004-0593-8
10.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P
10.1086/301903
10.1093/hmg/5.6.835
10.1111/j.1582-4934.2005.tb00350.x
10.1200/JCO.20.4.994
10.4161/cbt.1.1.33
10.1158/0008-5472.CAN-09-4563
10.1038/ng1294-399
10.1186/bcr70
10.1007/s12038-009-0048-9
10.1158/0008-5472.CAN-05-1241
10.1158/1078-0432.CCR-08-1211
10.1056/NEJM199705153362001
10.1093/hmg/6.2.285
10.1093/jnci/93.16.1215
10.1186/1471-2350-7-75
10.1038/ng1096-185
10.1002/humu.9082
10.1002/humu.9213
10.1136/jmg.2003.015867
10.1093/annonc/mdp037
10.1186/1471-2407-8-214
10.1371/journal.pone.0002024
10.1200/JCO.20.6.1480
10.1016/j.ejca.2006.01.055
10.1001/jama.1997.03550150046034
10.1073/pnas.081068398
10.1038/ng0495-439
ContentType Journal Article
Copyright Springer Science+Business Media, LLC 2012
Springer Science+Business Media New York 2012
Copyright_xml – notice: Springer Science+Business Media, LLC 2012
– notice: Springer Science+Business Media New York 2012
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
8FD
FR3
P64
RC3
DOI 10.1007/s12032-012-0294-9
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
Genetics Abstracts
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList Genetics Abstracts
ProQuest One Academic Middle East (New)
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1559-131X
EndPage 3281
ExternalDocumentID 3865294821
22752604
10_1007_s12032_012_0294_9
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations India
GeographicLocations_xml – name: India
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
2.D
203
28-
29M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
3V.
4.4
406
408
40E
53G
5GY
5RE
5VS
6NX
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABUWG
ABWNU
ABXPI
ACAOD
ACCUX
ACDTI
ACGFS
ACHSB
ACHVE
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GRRUI
H13
HF~
HG6
HMCUK
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXD
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NDZJH
NF0
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OVD
P19
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
PZZ
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
YLTOR
Z7U
Z82
Z87
Z8O
Z8V
Z91
ZMTXR
ZOVNA
ZXP
~A9
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
ABRTQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PUEGO
7X8
8FD
FR3
P64
RC3
ID FETCH-LOGICAL-c405t-1d46b80fc9d24e639d0aaaf31db1dfbb573483835b4fb7a393740cd05c9c98fe3
IEDL.DBID U2A
ISSN 1357-0560
1559-131X
IngestDate Thu Jul 10 21:57:05 EDT 2025
Fri Jul 11 04:43:32 EDT 2025
Sat Aug 23 14:49:09 EDT 2025
Thu Apr 03 07:07:06 EDT 2025
Tue Jul 01 01:49:07 EDT 2025
Thu Apr 24 23:09:46 EDT 2025
Fri Feb 21 02:33:49 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords SNPs
Mutations
Indian patients
Early-onset/sporadic breast cancer
Haplotype
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c405t-1d46b80fc9d24e639d0aaaf31db1dfbb573483835b4fb7a393740cd05c9c98fe3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 22752604
PQID 1732877580
PQPubID 30753
PageCount 10
ParticipantIDs proquest_miscellaneous_1758239886
proquest_miscellaneous_1220367588
proquest_journals_1732877580
pubmed_primary_22752604
crossref_citationtrail_10_1007_s12032_012_0294_9
crossref_primary_10_1007_s12032_012_0294_9
springer_journals_10_1007_s12032_012_0294_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-12-01
PublicationDateYYYYMMDD 2012-12-01
PublicationDate_xml – month: 12
  year: 2012
  text: 2012-12-01
  day: 01
PublicationDecade 2010
PublicationPlace Boston
PublicationPlace_xml – name: Boston
– name: United States
– name: Middlesex
PublicationTitle Medical oncology (Northwood, London, England)
PublicationTitleAbbrev Med Oncol
PublicationTitleAlternate Med Oncol
PublicationYear 2012
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References TohGTKangPLeeSSWLeeDSCLeeSYSelamatSMohd TaibNAYoonSYBRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family historyPLoS One20083e20241843150110.1371/journal.pone.0002024
DumitrescuRGCotarlaIUnderstanding breast cancer risk—where do we stand in 2005?J Cell Mol Med200592082211578417810.1111/j.1582-4934.2005.tb00350.x1:STN:280:DC%2BD2M7lt1Sjtw%3D%3D
RoaBBBoydAAVolcikKRichardsCSAshkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nat Genet199614185187884119110.1038/ng1096-1851:CAS:528:DyaK28XmtVKntLs%3D
FriedmanLSOstermeyerEASzaboCIDowdPLynchEDRowellSEKingMCConfirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten familiesNat Genet19948399404789449310.1038/ng1294-3991:CAS:528:DyaK2MXitl2hsb0%3D
AbeliovichDKaduriLLererIWeinbergNAmirGSagiMZlotogoraJHechingNThe founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60 % of ovarian cancer and 30 % of early-onset breast cancer patients among Ashkenazi womenAm J Hum Genet19976050551490429091:CAS:528:DyaK2sXhvFGjtLY%3D
HoussamiNCiattoSMartinelliFBonardiRDuffySWEarly detection of second breast cancers improves prognosis in breast cancer survivorsAnn Oncol200920150515101929731610.1093/annonc/mdp0371:STN:280:DC%2BD1MrnsVaqsw%3D%3D
FodorFHWestonABleiweissIJMcCurdyLDWalshMMTartterPIBrowerSTEngCMFrequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patientsAm J Hum Genet1998634551963450410.1086/3019031:STN:280:DyaK1c3pvFOqtA%3D%3D
MerajverSDPhamTMCaduffRFChenMPoyELCooneyKAWeberBLCollinsFSSomatic mutations in the BRCA1 gene in sporadic ovarian tumoursNat Genet19959439443779565210.1038/ng0495-4391:CAS:528:DyaK2MXkvV2ju7s%3D
KumarBVLakhotiaSAnkhatilRMadhavanJJayaprakashPGNairMKSomasundaramKGermline BRCA1 mutation analysis in Indian breast/ovarian cancer familiesCancer Biol Ther200211821121707591:CAS:528:DC%2BD3sXlsVOkug%3D%3D
LeeMSGreenRMarsillacSMCoquelleNWilliamsRSYeungTFooDHauDDComprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assaysCancer Res201070488048902051611510.1158/0008-5472.CAN-09-45631:CAS:528:DC%2BC3cXntlKlt7w%3D
De SilvaWKarunanayakeEHTennekoonKHAllenMAmarasingheIAngunawalaPZiardMHNovel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individualsBMC Cancer200882141866240910.1186/1471-2407-8-214
HedauSJainNHusainSAMandalAKRayGShahidMKantRGuptaVNovel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from IndiaBreast Cancer Res Treat2004881771861556480010.1007/s10549-004-0593-81:CAS:528:DC%2BD2MXoslOktw%3D%3D
EelesRAFuture possibilities in the prevention of breast cancer intervention strategies in BRCA1 and BRCA2 mutation carriersBreast Cancer Res200022832901125072210.1186/bcr701:CAS:528:DC%2BD3cXlvFOgt74%3D
SaxenaSSzaboCIChopinSBarjhouxLSinilnikovaOLenoirGGoldgarDEBhatanagerDBRCA1 and BRCA2 in Indian breast cancer patientsHum Mutat2002204734741244227310.1002/humu.9082
RuffnerHJoazeiroCAPHemmatiDHunterTVermaIMCancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivityPNAS USA200198513451391132025010.1073/pnas.0810683981:CAS:528:DC%2BD3MXjt1Ons7s%3D
DunningAMChianoMSmithNRDeardenJGoreMOakesSWilsonCStrattonMCommon BRCA1 variants and susceptibility to breast and ovarian cancer in the general populationHum Mol Genet19976285289906374910.1093/hmg/6.2.2851:CAS:528:DyaK2sXht1anur4%3D
StruewingJPHartgePWacholderSBakerSMBerlinMMcAdamsMTimmermanMMBrodyLCThe risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi JewsN Engl J Med199733614011408914567610.1056/NEJM1997051533620011:STN:280:DyaK2s3nsVShug%3D%3D
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, editors. Globocan 2008 v1.2. In: Cancer incidence and mortality worldwide: IARC Cancer Base No.10 Internet. Lyon France: International Agency for Research in Cancer; 2010. Available from: http://globocan.iarc.fr/.
Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P, editors. Cancer Incidence in Five Continents, No. 160. Volume IX. Lyon, France: IARC Scientific Publications; 2007. 896 pp.
MaloneKEDalingJRNealCSuterNMO’BrienCCushing-HaugenKJonasdottirTJThompsonJDFrequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma casesCancer200088139314021071762210.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P1:CAS:528:DC%2BD3cXisVentr0%3D
JohannesdottirGGudmundssonJBergthorssonJTArasonAAgnarssonBAEiriksdottirGJohannssonOTBorgAHigh prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patientsCancer Res1996563663366587060041:CAS:528:DyaK28XltVKksro%3D
ThorlaciusSSigurdssonSBjarnadottirHOlafsdottirGJonassonJGTryggvadottirLTuliniusHEyfjördJEStudy of a single BRCA2 mutation with high carrier frequency in a small populationAm J Hum Genet1997601079108491501551:STN:280:DyaK2s3psVequw%3D%3D
LomanNJohannssonOKristofferssonUOlssonHBorgAFamily history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancerJ Natl Cancer Inst200193121512231150476710.1093/jnci/93.16.12151:CAS:528:DC%2BD3MXms1OrtLc%3D
VaidyanathanKLakhotiaSRavishankarHMTabassumUMukherjeeGSomasundaramKBRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutationJ Biosci2009344154221980590310.1007/s12038-009-0048-91:CAS:528:DC%2BD1MXhtlCgtL3K
OlopadeOIGrushkoTANandaRHuoDAdvances in breast cancer: pathways to personalized medicineClin Cancer Res200814798879991908801510.1158/1078-0432.CCR-08-12111:CAS:528:DC%2BD1cXhsV2it73L
FrankTSDeffenbaughAMReidJEHulickMWardBELingenfelterBGumpperKLSchollTClinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individualsJ Clin Oncol200220148014901189609510.1200/JCO.20.6.14801:CAS:528:DC%2BD38XivFeisbY%3D
ValarmathiMTSawhneyMDeoSSVShuklaNKDasSNNovel germline mutations in the BRCA1 and BRCA2 genes in Indian breast-ovarian cancer familiesHum Mutat2004232051472292610.1002/humu.9213
AbkevichVZharkikhADeffenbaughAMFrankDChenYShattuckDSkolnickMHGutinAAnalysis of missense variation in human BRCA1 in the context of interspecific sequence variationJ Med Genet2004414925071523502010.1136/jmg.2003.0158671:CAS:528:DC%2BD2cXmvVymsLc%3D
http://relibrca.rellife.com.
ShihHANathansonKLSealSBlackwoodMARebbeckTRArmstrongKAWeberBLBRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancersClin Cancer Res2000642594264111062411:CAS:528:DC%2BD3cXovVSgtbc%3D
MauriceAEvansDGShentonAAshcroftLBaildamABarrLByrneGBundredNScreening younger women with a family history of breast cancer—does early detection improve outcome?Eur J Cancer200642138513901675091010.1016/j.ejca.2006.01.0551:STN:280:DC%2BD28zmvFyitQ%3D%3D
Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. In: Cancer incidence in five continents, No. 155. Volume VIII. Lyon, France: IARC Scientific Publications; 2002. 781 pp.
JudkinsTHendricksonBCDeffenbaughAMEliasonKLeclairBNortonMJWardBEPrussDApplication of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutationsCancer Res20056510096101031626703610.1158/0008-5472.CAN-05-12411:CAS:528:DC%2BD2MXhtFKkt7rF
ShihHACouchFJNathasonKLBlackwoodMARebbeckTRArmstrongKACalzoneKStopferJBRCA1 and BRCA2 mutations frequency in women evaluated in a breast cancer risk evaluation clinicJ Clin Oncol2002209949991184482210.1200/JCO.20.4.9941:CAS:528:DC%2BD38XitFOqtbc%3D
SaxenaSChakraborthyAKauhsalMKotwalSBhatanagerDMohilRChintamaniCAggarwalAKContribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in northern IndiaBMC Med Genet20067751701816010.1186/1471-2350-7-75
RajkumarTSoumittraNNancyNKSwaminathanRSrideviVShantaVBRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South IndiaAsian Pac J Cancer Prev2003420320814507240
Shattuck-EidensDOliphantAMcClureMMcBrideCGupteJRubanoTPrussDTavtigianSVBRCA1 sequence analysis in women at high risk for susceptibility mutations risk factor analysis and implications for genetic testingJAMA199727812421250933326510.1001/jama.1997.035501500460341:CAS:528:DyaK2sXmvFemtLk%3D
DurocherFShattuck-EidensDMcClureMLabrieFSkolnickMHGoldgarDESimardJComparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populationsHum Mol Genet19965835842877660010.1093/hmg/5.6.8351:CAS:528:DyaK28XjsFGmur4%3D
National Cancer Registry ProgramConsolidated report of the population based cancer registries2001New DelhiIndian Council of Medical Research
Breast Cancer Information Core (BIC) Database—NHGRI: research server: http://research.nhgri.nih.gov/bic/.
T Rajkumar (294_CR20) 2003; 4
MS Lee (294_CR31) 2010; 70
GT Toh (294_CR37) 2008; 3
294_CR41
N Houssami (294_CR40) 2009; 20
LS Friedman (294_CR35) 1994; 8
RG Dumitrescu (294_CR5) 2005; 9
V Abkevich (294_CR29) 2004; 41
S Saxena (294_CR17) 2006; 7
T Judkins (294_CR22) 2005; 65
HA Shih (294_CR27) 2002; 20
SD Merajver (294_CR38) 1995; 9
S Hedau (294_CR14) 2004; 88
D Abeliovich (294_CR23) 1997; 60
TS Frank (294_CR21) 2002; 20
AM Dunning (294_CR33) 1997; 6
W Silva De (294_CR36) 2008; 8
MT Valarmathi (294_CR18) 2004; 23
JP Struewing (294_CR11) 1997; 336
HA Shih (294_CR28) 2000; 6
BV Kumar (294_CR15) 2002; 1
KE Malone (294_CR26) 2000; 88
H Ruffner (294_CR32) 2001; 98
D Shattuck-Eidens (294_CR30) 1997; 278
OI Olopade (294_CR6) 2008; 14
FH Fodor (294_CR9) 1998; 63
294_CR8
294_CR1
S Thorlacius (294_CR24) 1997; 60
294_CR2
RA Eeles (294_CR7) 2000; 2
BB Roa (294_CR10) 1996; 14
294_CR3
National Cancer Registry Program (294_CR4) 2001
A Maurice (294_CR39) 2006; 42
F Durocher (294_CR34) 1996; 5
S Saxena (294_CR16) 2002; 20
K Vaidyanathan (294_CR19) 2009; 34
G Johannesdottir (294_CR12) 1996; 56
S Thorlacius (294_CR13) 1997; 60
N Loman (294_CR25) 2001; 93
14507240 - Asian Pac J Cancer Prev. 2003 Jul-Sep;4(3):203-8
15564800 - Breast Cancer Res Treat. 2004 Nov;88(2):177-86
16267036 - Cancer Res. 2005 Nov 1;65(21):10096-103
9063749 - Hum Mol Genet. 1997 Feb;6(2):285-9
7795652 - Nat Genet. 1995 Apr;9(4):439-43
19805903 - J Biosci. 2009 Sep;34(3):415-22
19297316 - Ann Oncol. 2009 Sep;20(9):1505-10
18431501 - PLoS One. 2008 Apr 23;3(4):e2024
9145676 - N Engl J Med. 1997 May 15;336(20):1401-8
17018160 - BMC Med Genet. 2006 Oct 04;7:75
15235020 - J Med Genet. 2004 Jul;41(7):492-507
9150155 - Am J Hum Genet. 1997 May;60(5):1079-84
9042909 - Am J Hum Genet. 1997 Mar;60(3):505-14
8841191 - Nat Genet. 1996 Oct;14(2):185-7
15784178 - J Cell Mol Med. 2005 Jan-Mar;9(1):208-21
9333265 - JAMA. 1997 Oct 15;278(15):1242-50
8706004 - Cancer Res. 1996 Aug 15;56(16):3663-5
11896095 - J Clin Oncol. 2002 Mar 15;20(6):1480-90
11250722 - Breast Cancer Res. 2000;2(4):283-90
18662409 - BMC Cancer. 2008 Jul 29;8:214
16750910 - Eur J Cancer. 2006 Jul;42(10):1385-90
11504767 - J Natl Cancer Inst. 2001 Aug 15;93(16):1215-23
11320250 - Proc Natl Acad Sci U S A. 2001 Apr 24;98 (9):5134-9
10717622 - Cancer. 2000 Mar 15;88(6):1393-402
9634504 - Am J Hum Genet. 1998 Jul;63(1):45-51
19088015 - Clin Cancer Res. 2008 Dec 15;14(24):7988-99
7894493 - Nat Genet. 1994 Dec;8(4):399-404
20516115 - Cancer Res. 2010 Jun 15;70(12):4880-90
11106241 - Clin Cancer Res. 2000 Nov;6(11):4259-64
12170759 - Cancer Biol Ther. 2002 Jan-Feb;1(1):18-21
11844822 - J Clin Oncol. 2002 Feb 15;20(4):994-9
12442273 - Hum Mutat. 2002 Dec;20(6):473-4
8776600 - Hum Mol Genet. 1996 Jun;5(6):835-42
14722926 - Hum Mutat. 2004 Feb;23(2):205
References_xml – reference: HoussamiNCiattoSMartinelliFBonardiRDuffySWEarly detection of second breast cancers improves prognosis in breast cancer survivorsAnn Oncol200920150515101929731610.1093/annonc/mdp0371:STN:280:DC%2BD1MrnsVaqsw%3D%3D
– reference: RajkumarTSoumittraNNancyNKSwaminathanRSrideviVShantaVBRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South IndiaAsian Pac J Cancer Prev2003420320814507240
– reference: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P, editors. Cancer Incidence in Five Continents, No. 160. Volume IX. Lyon, France: IARC Scientific Publications; 2007. 896 pp.
– reference: JudkinsTHendricksonBCDeffenbaughAMEliasonKLeclairBNortonMJWardBEPrussDApplication of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutationsCancer Res20056510096101031626703610.1158/0008-5472.CAN-05-12411:CAS:528:DC%2BD2MXhtFKkt7rF
– reference: SaxenaSSzaboCIChopinSBarjhouxLSinilnikovaOLenoirGGoldgarDEBhatanagerDBRCA1 and BRCA2 in Indian breast cancer patientsHum Mutat2002204734741244227310.1002/humu.9082
– reference: DurocherFShattuck-EidensDMcClureMLabrieFSkolnickMHGoldgarDESimardJComparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populationsHum Mol Genet19965835842877660010.1093/hmg/5.6.8351:CAS:528:DyaK28XjsFGmur4%3D
– reference: LomanNJohannssonOKristofferssonUOlssonHBorgAFamily history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancerJ Natl Cancer Inst200193121512231150476710.1093/jnci/93.16.12151:CAS:528:DC%2BD3MXms1OrtLc%3D
– reference: De SilvaWKarunanayakeEHTennekoonKHAllenMAmarasingheIAngunawalaPZiardMHNovel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individualsBMC Cancer200882141866240910.1186/1471-2407-8-214
– reference: National Cancer Registry ProgramConsolidated report of the population based cancer registries2001New DelhiIndian Council of Medical Research
– reference: AbeliovichDKaduriLLererIWeinbergNAmirGSagiMZlotogoraJHechingNThe founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60 % of ovarian cancer and 30 % of early-onset breast cancer patients among Ashkenazi womenAm J Hum Genet19976050551490429091:CAS:528:DyaK2sXhvFGjtLY%3D
– reference: ThorlaciusSSigurdssonSBjarnadottirHOlafsdottirGJonassonJGTryggvadottirLTuliniusHEyfjördJEStudy of a single BRCA2 mutation with high carrier frequency in a small populationAm J Hum Genet1997601079108491501551:STN:280:DyaK2s3psVequw%3D%3D
– reference: KumarBVLakhotiaSAnkhatilRMadhavanJJayaprakashPGNairMKSomasundaramKGermline BRCA1 mutation analysis in Indian breast/ovarian cancer familiesCancer Biol Ther200211821121707591:CAS:528:DC%2BD3sXlsVOkug%3D%3D
– reference: MerajverSDPhamTMCaduffRFChenMPoyELCooneyKAWeberBLCollinsFSSomatic mutations in the BRCA1 gene in sporadic ovarian tumoursNat Genet19959439443779565210.1038/ng0495-4391:CAS:528:DyaK2MXkvV2ju7s%3D
– reference: JohannesdottirGGudmundssonJBergthorssonJTArasonAAgnarssonBAEiriksdottirGJohannssonOTBorgAHigh prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patientsCancer Res1996563663366587060041:CAS:528:DyaK28XltVKksro%3D
– reference: DunningAMChianoMSmithNRDeardenJGoreMOakesSWilsonCStrattonMCommon BRCA1 variants and susceptibility to breast and ovarian cancer in the general populationHum Mol Genet19976285289906374910.1093/hmg/6.2.2851:CAS:528:DyaK2sXht1anur4%3D
– reference: OlopadeOIGrushkoTANandaRHuoDAdvances in breast cancer: pathways to personalized medicineClin Cancer Res200814798879991908801510.1158/1078-0432.CCR-08-12111:CAS:528:DC%2BD1cXhsV2it73L
– reference: SaxenaSChakraborthyAKauhsalMKotwalSBhatanagerDMohilRChintamaniCAggarwalAKContribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in northern IndiaBMC Med Genet20067751701816010.1186/1471-2350-7-75
– reference: FriedmanLSOstermeyerEASzaboCIDowdPLynchEDRowellSEKingMCConfirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten familiesNat Genet19948399404789449310.1038/ng1294-3991:CAS:528:DyaK2MXitl2hsb0%3D
– reference: LeeMSGreenRMarsillacSMCoquelleNWilliamsRSYeungTFooDHauDDComprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assaysCancer Res201070488048902051611510.1158/0008-5472.CAN-09-45631:CAS:528:DC%2BC3cXntlKlt7w%3D
– reference: Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. In: Cancer incidence in five continents, No. 155. Volume VIII. Lyon, France: IARC Scientific Publications; 2002. 781 pp.
– reference: StruewingJPHartgePWacholderSBakerSMBerlinMMcAdamsMTimmermanMMBrodyLCThe risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi JewsN Engl J Med199733614011408914567610.1056/NEJM1997051533620011:STN:280:DyaK2s3nsVShug%3D%3D
– reference: Breast Cancer Information Core (BIC) Database—NHGRI: research server: http://research.nhgri.nih.gov/bic/.
– reference: MauriceAEvansDGShentonAAshcroftLBaildamABarrLByrneGBundredNScreening younger women with a family history of breast cancer—does early detection improve outcome?Eur J Cancer200642138513901675091010.1016/j.ejca.2006.01.0551:STN:280:DC%2BD28zmvFyitQ%3D%3D
– reference: DumitrescuRGCotarlaIUnderstanding breast cancer risk—where do we stand in 2005?J Cell Mol Med200592082211578417810.1111/j.1582-4934.2005.tb00350.x1:STN:280:DC%2BD2M7lt1Sjtw%3D%3D
– reference: ValarmathiMTSawhneyMDeoSSVShuklaNKDasSNNovel germline mutations in the BRCA1 and BRCA2 genes in Indian breast-ovarian cancer familiesHum Mutat2004232051472292610.1002/humu.9213
– reference: MaloneKEDalingJRNealCSuterNMO’BrienCCushing-HaugenKJonasdottirTJThompsonJDFrequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma casesCancer200088139314021071762210.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P1:CAS:528:DC%2BD3cXisVentr0%3D
– reference: RuffnerHJoazeiroCAPHemmatiDHunterTVermaIMCancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivityPNAS USA200198513451391132025010.1073/pnas.0810683981:CAS:528:DC%2BD3MXjt1Ons7s%3D
– reference: RoaBBBoydAAVolcikKRichardsCSAshkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nat Genet199614185187884119110.1038/ng1096-1851:CAS:528:DyaK28XmtVKntLs%3D
– reference: AbkevichVZharkikhADeffenbaughAMFrankDChenYShattuckDSkolnickMHGutinAAnalysis of missense variation in human BRCA1 in the context of interspecific sequence variationJ Med Genet2004414925071523502010.1136/jmg.2003.0158671:CAS:528:DC%2BD2cXmvVymsLc%3D
– reference: ShihHACouchFJNathasonKLBlackwoodMARebbeckTRArmstrongKACalzoneKStopferJBRCA1 and BRCA2 mutations frequency in women evaluated in a breast cancer risk evaluation clinicJ Clin Oncol2002209949991184482210.1200/JCO.20.4.9941:CAS:528:DC%2BD38XitFOqtbc%3D
– reference: http://relibrca.rellife.com.
– reference: FodorFHWestonABleiweissIJMcCurdyLDWalshMMTartterPIBrowerSTEngCMFrequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patientsAm J Hum Genet1998634551963450410.1086/3019031:STN:280:DyaK1c3pvFOqtA%3D%3D
– reference: FrankTSDeffenbaughAMReidJEHulickMWardBELingenfelterBGumpperKLSchollTClinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individualsJ Clin Oncol200220148014901189609510.1200/JCO.20.6.14801:CAS:528:DC%2BD38XivFeisbY%3D
– reference: Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, editors. Globocan 2008 v1.2. In: Cancer incidence and mortality worldwide: IARC Cancer Base No.10 Internet. Lyon France: International Agency for Research in Cancer; 2010. Available from: http://globocan.iarc.fr/.
– reference: EelesRAFuture possibilities in the prevention of breast cancer intervention strategies in BRCA1 and BRCA2 mutation carriersBreast Cancer Res200022832901125072210.1186/bcr701:CAS:528:DC%2BD3cXlvFOgt74%3D
– reference: ShihHANathansonKLSealSBlackwoodMARebbeckTRArmstrongKAWeberBLBRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancersClin Cancer Res2000642594264111062411:CAS:528:DC%2BD3cXovVSgtbc%3D
– reference: HedauSJainNHusainSAMandalAKRayGShahidMKantRGuptaVNovel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from IndiaBreast Cancer Res Treat2004881771861556480010.1007/s10549-004-0593-81:CAS:528:DC%2BD2MXoslOktw%3D%3D
– reference: VaidyanathanKLakhotiaSRavishankarHMTabassumUMukherjeeGSomasundaramKBRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutationJ Biosci2009344154221980590310.1007/s12038-009-0048-91:CAS:528:DC%2BD1MXhtlCgtL3K
– reference: Shattuck-EidensDOliphantAMcClureMMcBrideCGupteJRubanoTPrussDTavtigianSVBRCA1 sequence analysis in women at high risk for susceptibility mutations risk factor analysis and implications for genetic testingJAMA199727812421250933326510.1001/jama.1997.035501500460341:CAS:528:DyaK2sXmvFemtLk%3D
– reference: TohGTKangPLeeSSWLeeDSCLeeSYSelamatSMohd TaibNAYoonSYBRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family historyPLoS One20083e20241843150110.1371/journal.pone.0002024
– volume: 88
  start-page: 177
  year: 2004
  ident: 294_CR14
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-004-0593-8
– volume: 88
  start-page: 1393
  year: 2000
  ident: 294_CR26
  publication-title: Cancer
  doi: 10.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P
– volume: 63
  start-page: 45
  year: 1998
  ident: 294_CR9
  publication-title: Am J Hum Genet
  doi: 10.1086/301903
– volume: 4
  start-page: 203
  year: 2003
  ident: 294_CR20
  publication-title: Asian Pac J Cancer Prev
– volume: 5
  start-page: 835
  year: 1996
  ident: 294_CR34
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/5.6.835
– volume: 9
  start-page: 208
  year: 2005
  ident: 294_CR5
  publication-title: J Cell Mol Med
  doi: 10.1111/j.1582-4934.2005.tb00350.x
– volume: 6
  start-page: 4259
  year: 2000
  ident: 294_CR28
  publication-title: Clin Cancer Res
– volume: 20
  start-page: 994
  year: 2002
  ident: 294_CR27
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.20.4.994
– ident: 294_CR8
– volume: 1
  start-page: 18
  year: 2002
  ident: 294_CR15
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.1.1.33
– volume: 70
  start-page: 4880
  year: 2010
  ident: 294_CR31
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-4563
– volume: 8
  start-page: 399
  year: 1994
  ident: 294_CR35
  publication-title: Nat Genet
  doi: 10.1038/ng1294-399
– volume: 2
  start-page: 283
  year: 2000
  ident: 294_CR7
  publication-title: Breast Cancer Res
  doi: 10.1186/bcr70
– volume: 34
  start-page: 415
  year: 2009
  ident: 294_CR19
  publication-title: J Biosci
  doi: 10.1007/s12038-009-0048-9
– ident: 294_CR1
– ident: 294_CR3
– volume: 65
  start-page: 10096
  year: 2005
  ident: 294_CR22
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-1241
– volume-title: Consolidated report of the population based cancer registries
  year: 2001
  ident: 294_CR4
– volume: 14
  start-page: 7988
  year: 2008
  ident: 294_CR6
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-08-1211
– volume: 60
  start-page: 1079
  year: 1997
  ident: 294_CR24
  publication-title: Am J Hum Genet
– volume: 60
  start-page: 1079
  year: 1997
  ident: 294_CR13
  publication-title: Am J Hum Genet
– volume: 56
  start-page: 3663
  year: 1996
  ident: 294_CR12
  publication-title: Cancer Res
– volume: 336
  start-page: 1401
  year: 1997
  ident: 294_CR11
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199705153362001
– volume: 6
  start-page: 285
  year: 1997
  ident: 294_CR33
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/6.2.285
– ident: 294_CR41
– volume: 93
  start-page: 1215
  year: 2001
  ident: 294_CR25
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/93.16.1215
– volume: 7
  start-page: 75
  year: 2006
  ident: 294_CR17
  publication-title: BMC Med Genet
  doi: 10.1186/1471-2350-7-75
– volume: 14
  start-page: 185
  year: 1996
  ident: 294_CR10
  publication-title: Nat Genet
  doi: 10.1038/ng1096-185
– volume: 20
  start-page: 473
  year: 2002
  ident: 294_CR16
  publication-title: Hum Mutat
  doi: 10.1002/humu.9082
– volume: 23
  start-page: 205
  year: 2004
  ident: 294_CR18
  publication-title: Hum Mutat
  doi: 10.1002/humu.9213
– volume: 41
  start-page: 492
  year: 2004
  ident: 294_CR29
  publication-title: J Med Genet
  doi: 10.1136/jmg.2003.015867
– ident: 294_CR2
– volume: 20
  start-page: 1505
  year: 2009
  ident: 294_CR40
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdp037
– volume: 8
  start-page: 214
  year: 2008
  ident: 294_CR36
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-8-214
– volume: 3
  start-page: e2024
  year: 2008
  ident: 294_CR37
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0002024
– volume: 20
  start-page: 1480
  year: 2002
  ident: 294_CR21
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.20.6.1480
– volume: 60
  start-page: 505
  year: 1997
  ident: 294_CR23
  publication-title: Am J Hum Genet
– volume: 42
  start-page: 1385
  year: 2006
  ident: 294_CR39
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2006.01.055
– volume: 278
  start-page: 1242
  year: 1997
  ident: 294_CR30
  publication-title: JAMA
  doi: 10.1001/jama.1997.03550150046034
– volume: 98
  start-page: 5134
  year: 2001
  ident: 294_CR32
  publication-title: PNAS USA
  doi: 10.1073/pnas.081068398
– volume: 9
  start-page: 439
  year: 1995
  ident: 294_CR38
  publication-title: Nat Genet
  doi: 10.1038/ng0495-439
– reference: 15564800 - Breast Cancer Res Treat. 2004 Nov;88(2):177-86
– reference: 14507240 - Asian Pac J Cancer Prev. 2003 Jul-Sep;4(3):203-8
– reference: 15784178 - J Cell Mol Med. 2005 Jan-Mar;9(1):208-21
– reference: 8841191 - Nat Genet. 1996 Oct;14(2):185-7
– reference: 8706004 - Cancer Res. 1996 Aug 15;56(16):3663-5
– reference: 19088015 - Clin Cancer Res. 2008 Dec 15;14(24):7988-99
– reference: 7894493 - Nat Genet. 1994 Dec;8(4):399-404
– reference: 9145676 - N Engl J Med. 1997 May 15;336(20):1401-8
– reference: 11844822 - J Clin Oncol. 2002 Feb 15;20(4):994-9
– reference: 16750910 - Eur J Cancer. 2006 Jul;42(10):1385-90
– reference: 16267036 - Cancer Res. 2005 Nov 1;65(21):10096-103
– reference: 11504767 - J Natl Cancer Inst. 2001 Aug 15;93(16):1215-23
– reference: 17018160 - BMC Med Genet. 2006 Oct 04;7:75
– reference: 20516115 - Cancer Res. 2010 Jun 15;70(12):4880-90
– reference: 7795652 - Nat Genet. 1995 Apr;9(4):439-43
– reference: 15235020 - J Med Genet. 2004 Jul;41(7):492-507
– reference: 11106241 - Clin Cancer Res. 2000 Nov;6(11):4259-64
– reference: 14722926 - Hum Mutat. 2004 Feb;23(2):205
– reference: 11320250 - Proc Natl Acad Sci U S A. 2001 Apr 24;98 (9):5134-9
– reference: 9634504 - Am J Hum Genet. 1998 Jul;63(1):45-51
– reference: 9333265 - JAMA. 1997 Oct 15;278(15):1242-50
– reference: 9063749 - Hum Mol Genet. 1997 Feb;6(2):285-9
– reference: 12442273 - Hum Mutat. 2002 Dec;20(6):473-4
– reference: 19805903 - J Biosci. 2009 Sep;34(3):415-22
– reference: 9150155 - Am J Hum Genet. 1997 May;60(5):1079-84
– reference: 19297316 - Ann Oncol. 2009 Sep;20(9):1505-10
– reference: 18431501 - PLoS One. 2008 Apr 23;3(4):e2024
– reference: 9042909 - Am J Hum Genet. 1997 Mar;60(3):505-14
– reference: 11896095 - J Clin Oncol. 2002 Mar 15;20(6):1480-90
– reference: 10717622 - Cancer. 2000 Mar 15;88(6):1393-402
– reference: 11250722 - Breast Cancer Res. 2000;2(4):283-90
– reference: 8776600 - Hum Mol Genet. 1996 Jun;5(6):835-42
– reference: 18662409 - BMC Cancer. 2008 Jul 29;8:214
– reference: 12170759 - Cancer Biol Ther. 2002 Jan-Feb;1(1):18-21
SSID ssj0021529
Score 2.065702
Snippet We examined BRCA1/2 mutations and single nucleotide polymorphisms (SNPs) for identification of BRCA1 haplotypes, in early-onset breast cancer patients and...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3272
SubjectTerms Adult
Age of Onset
Breast cancer
Breast Neoplasms - epidemiology
Breast Neoplasms - genetics
DNA Mutational Analysis
Female
Genes, BRCA1
Genes, BRCA2
Haplotypes
Hematology
Humans
India - epidemiology
Internal Medicine
Medicine
Medicine & Public Health
Middle Aged
Mutation
Oncology
Original Paper
Pathology
Polymorphism, Single Nucleotide
Reverse Transcriptase Polymerase Chain Reaction
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9wwDI8Ge-EFMbFB-ZgyaU-giLSXNskTYmgIJg1NfEj3VuWrAgnSg_b-f-xe7m4T2j20L3Uly3ZiO3Z-JuQ7t9xJWRmmR1VgIlSKqUoF1oArVxhi-4CXk39fV5f34te4HKcDty61Vc73xGGj9q3DM_KTHFFlJES3_HTywnBqFFZX0wiNNfIRocuwpUuOlwkX-CY9JFylZODoF1XN4eocjg6HRBqeQgum__VL74LNd4XSwf9cbJHNFDjSs5mmP5EPIW6T-OPm_Cw_wXdBwRQCfZ72qRp9e_2noyZ6OtDQBzN5avHAtaOPkQbENWbYSd1Ti33pPXWo_1eagFY72jb0KqL10NA_xEcH4fpncn_x8-78kqUJCsxBINaz3IvKKt447QvQw0h7boxpRrm3uW-sLRHbBnLU0orGSoPgeII7z0unnVZNGH0h67GNYZdQ52TDQym1FUpopYzPpddahkJVDmKMjPC5_GqX4MVxysVTvQRGRpHXIPIaRV7rjBwtfpnMsDVWER_MlVKnZdbVS6PIyLfFZ1ggWPUwMbRToCmw1go0agUNfEYgRFVlZGem8AVHRSFLSPpERo7nFvAXA_9jd281u_tko0DbG_piDsh6_zoNhxDd9PbrYMJvm1zycg
  priority: 102
  providerName: ProQuest
Title BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity
URI https://link.springer.com/article/10.1007/s12032-012-0294-9
https://www.ncbi.nlm.nih.gov/pubmed/22752604
https://www.proquest.com/docview/1732877580
https://www.proquest.com/docview/1220367588
https://www.proquest.com/docview/1758239886
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9QwDLfYJiFeEN8UxilIPIEi0lzbJI-36cYA7TQNTjqeqnxVQxq9ae098N9j99oONJjEQ9uHuK1lO7VdO78AvBFOeKUKy820iDyLhea60JFX6Mo1hdgh0uLkk0VxvMw-rfJVv467Gbrdh5Jk96W-XuxGm31j6ouHNBk3O7CXU-qORryUszHLQodkuiwrVxy9-1jK_Nsj_nRGNyLMG9XRzukcPYD7fbTIZlv1PoQ7sX4Ed0_6evhjqA_ODmfpezpLhqYQ2Y9N21ejvyxOG2brwDoadm4vL9b0w7Vh32sWCdeYUyd1yxz1pbfMk_6vWA-02rB1xT7WZD0stuc1vrD9-QSWR_Ovh8e830GBewzEWp6GrHBaVN4EiXqYmiCstdU0DS4NlXM5Ydtgjpq7rHLKEjheJnwQuTfe6CpOn8Juva7jc2Deq0rEXBmX6cxobUOqgjEqSl14jDESEIMoS9_Di9MuFxflNTAySb9E6Zck_dIk8Ha85XKLrXEb8f6gn7KfZk2ZEtSQwpRHJPB6HMYJQlUPW8f1Bmkk1VqRRt9Cg8MEhKiLBJ5tdT9yJKXKMenLEng3GMNvDPyL3Rf_Rf0S7kmyyq5NZh9226tNfIXBTusmsKNWagJ7sw_fPs_xejBfnJ5NOpP_Bdca9iU
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6V7QEuCMQrUMBIcAFZTZyH7QNCbWm1S9tVVVqptxA_olYqydLNCvGn-I3MZJMUVLG3HpKLJ9Fo_Nme8djfALwNTWilzAqu48zzxGeKq0x5XuJSrsjFdp4uJx9Os_Fp8uUsPVuD3_1dGDpW2c-J7UTtakt75JsRscpI9G7DT7MfnKpGUXa1L6GxhMW-__UTQ7b5x8ln7N93QuztnuyMeVdVgFt0ThoeuSQzKiytdgJ1i7ULi6Io48iZyJXGpMT3gnFbapLSyIII45LQujC12mpV-hj_ewfWkxhDmRGsb-9Oj46HEA9XQ92GeKnk6FoMedT2sh4VK8fQHR-hE67_XQlvuLc3UrPtirf3AO53rirbWmLrIaz56hFU28c7W9EmvQVD8Hn2fdF0-e-v06M5KyrHWhl2Xswua9rinbOLinliUuZ0drthhk7CN8wS4q5YR-06Z3XJJhXhlfnmvLqwGCA8htNbse4TGFV15Z8Bs1aWoU-lNolKtFKFi6TTWnqhMoteTQBhb7_cdoTmVFfjMr-mYiaT52jynEye6wDeD5_Mlmweq4Q3-k7Ju4E9z69hGMCboRmHJOVZisrXC5QRlN1FGbVCBpuJelFlATxddvigkRAyxTAzCeBDj4C_FPifus9Xq_sa7o5PDg_yg8l0_wXcE4TD9lTOBoyaq4V_ib5VY151gGbw7bbH0B-majGk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIiEuqIiXocAiwQW0ir1-7O4BodISNRSiCqiUm_E-rFYqdlo7Qvw1fh0zjp2AKnLrwbl4Yo1mv_HOeGa_AXgZmtBKmRVcx5nnic8UV5nyvMStXFGI7TwdTv48zQ5Pko-zdLYFv4ezMNRWObwTuxe1qy19Ix9FxCojMboNR2XfFnF8MH43v-A0QYoqrcM4jSVEjvyvn5i-NW8nB7jWr4QYf_i2f8j7CQPcYqDS8sglmVFhabUTqGesXVgURRlHzkSuNCYl7hfM4VKTlEYWRB6XhNaFqdVWq9LH-NwbcFPGaUQ-JmfrZA_3Rd0le6nkGGSsKqrdsT0aW45JPF5CJ1z_uydeCXSvFGm7vW-8A3f6oJXtLVF2F7Z8dQ-q91_296IR_QqGMPTsx6LtK-Ffp8cNKyrHOhl2WszPa_rY27CzinniVObUxd0yQz3xLbOEvUvWk7w2rC7ZpCLkMt-eVmcWU4X7cHIttn0A21Vd-UfArJVl6FOpTaISrVThIum0ll6ozGJ8E0A42C-3PbU5Tdg4z9ekzGTyHE2ek8lzHcDr1V_mS16PTcK7w6LkvYs3-RqQAbxY3UbnpIpLUfl6gTKC6rwoozbI4G0iYVRZAA-XC77SSAiZYsKZBPBmQMBfCvxP3ceb1X0Ot9Bz8k-T6dETuC0Ihl17zi5st5cL_xSDrNY869DM4Pt1u88fwss0dA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=BRCA1%2FBRCA2+gene+mutations%2FSNPs+and+BRCA1+haplotypes+in+early-onset+breast+cancer+patients+of+Indian+ethnicity&rft.jtitle=Medical+oncology+%28Northwood%2C+London%2C+England%29&rft.au=Juwle%2C+Abida&rft.au=Saranath%2C+Dhananjaya&rft.date=2012-12-01&rft.pub=Springer+US&rft.issn=1357-0560&rft.eissn=1559-131X&rft.volume=29&rft.issue=5&rft.spage=3272&rft.epage=3281&rft_id=info:doi/10.1007%2Fs12032-012-0294-9&rft.externalDocID=10_1007_s12032_012_0294_9
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1357-0560&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1357-0560&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1357-0560&client=summon